• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有生化妊娠史的女性接受辅助生殖治疗后的活产预测因素。

Predictors of live birth in women with a history of biochemical pregnancies after assisted reproduction treatment.

机构信息

Department of Cellular Biology, Functional Biology and Physical Anthropology, Faculty of Biological Sciences, University of Valencia, Dr. Moliner 50, Burjassot, Valencia, 46100, Spain; Research Unit on Women's Health-Institute of Health Research INCLIVA, Av. de Menéndez y Pelayo, 4, 46010, Valencia, Spain.

Research Unit on Women's Health-Institute of Health Research INCLIVA, Av. de Menéndez y Pelayo, 4, 46010, Valencia, Spain; Service of Obstetrics and Gynecology, University Clinic Hospital, Av. de Blasco Ibáñez, 17, 46010, Valencia, Spain.

出版信息

Eur J Obstet Gynecol Reprod Biol. 2020 May;248:198-203. doi: 10.1016/j.ejogrb.2020.03.030. Epub 2020 Mar 19.

DOI:10.1016/j.ejogrb.2020.03.030
PMID:32240893
Abstract

OBJECTIVES

To ascertain whether women with a history of biochemical pregnancies (BPs) in in-vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) treatment cycles have decreased chances of live birth (LB); and (2) to build a predictive model for LB in this particular population of infertile women.

METHODS

In order to achieve the first objective, data from 1536 women that had a LB using autologous fresh or frozen embryos, or dropped out of further IVF/ICSI treatments after completing one to three unsuccessful treatment cycles were retrospectively analyzed. A subpopulation of 90 women that experienced one or more BPs in our assisted reproduction unit were selected to build a predictive logistic regression model for LB.

RESULTS

LB percentages significantly decreased from a value of 55.3 % in women with no history of previous BPs to 30.9 % and 11.1 % in women that displayed a history of one or more than one BP, respectively. Three out of 35 selected potential predictors were finally included into the model: "number of the last embryo transfer cycle resulting in a BP", "women's age", and "oligo-, astheno-, and/or teratozoospermia". The value of the c-statistic was 0.819 (asymptotic 95 % CI: 0.724-0.913). The model adequately fitted the data with no significant over or underestimation of predictor effects.

CONCLUSION

(1) A history of BPs is negatively associated with later chance of LB in women undergoing a series of IVF/ICSI treatment cycles; and (2) LB probability of women with a history of BPs can be predicted using a model with excellent discriminatory capacity.

摘要

目的

确定体外受精(IVF)/卵胞浆内单精子注射(ICSI)治疗周期中曾有生化妊娠(BP)史的女性活产(LB)的机会是否降低;并(2)为该特定不孕女性人群建立 LB 的预测模型。

方法

为了实现第一个目标,回顾性分析了 1536 名使用自体新鲜或冷冻胚胎获得 LB 的女性的数据,或在完成一至三个不成功的治疗周期后退出进一步的 IVF/ICSI 治疗。选择我们辅助生殖单位中经历过一次或多次 BP 的 90 名女性亚群,建立 LB 的预测逻辑回归模型。

结果

LB 的百分比从无先前 BP 史的女性的 55.3%显著降低至经历过一次或多次 BP 的女性的 30.9%和 11.1%。35 个选定的潜在预测因子中有 3 个最终纳入模型:“导致 BP 的最后一个胚胎移植周期的数量”、“女性年龄”和“少精症、弱精症和/或畸形精症”。C 统计量的值为 0.819(渐近 95%置信区间:0.724-0.913)。该模型充分拟合了数据,没有显著的预测因子效应过高或过低估计。

结论

(1)BP 史与接受一系列 IVF/ICSI 治疗周期的女性以后 LB 的机会呈负相关;(2)使用具有出色判别能力的模型可以预测有 BP 史的女性的 LB 概率。

相似文献

1
Predictors of live birth in women with a history of biochemical pregnancies after assisted reproduction treatment.有生化妊娠史的女性接受辅助生殖治疗后的活产预测因素。
Eur J Obstet Gynecol Reprod Biol. 2020 May;248:198-203. doi: 10.1016/j.ejogrb.2020.03.030. Epub 2020 Mar 19.
2
A predictive model for women's assisted fecundity before starting the first IVF/ICSI treatment cycle.预测女性在开始第一次 IVF/ICSI 治疗周期前的辅助生育能力的模型。
J Assist Reprod Genet. 2020 Jan;37(1):171-180. doi: 10.1007/s10815-019-01642-3. Epub 2019 Dec 3.
3
Cumulative probabilities of live birth across multiple complete IVF/ICSI cycles: a call for attention.多次完整 IVF/ICSI 周期后的活产累积概率:需要关注。
J Assist Reprod Genet. 2020 Jan;37(1):141-148. doi: 10.1007/s10815-019-01608-5. Epub 2019 Dec 5.
4
The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.胞浆内单精子注射在高龄产妇非男性因素不孕中的作用。
Hum Reprod. 2017 Jan;32(1):119-124. doi: 10.1093/humrep/dew298. Epub 2016 Nov 16.
5
ICSI does not increase the cumulative live birth rate in non-male factor infertility.ICSI 并不会增加非男性因素不孕的累积活产率。
Hum Reprod. 2018 Jul 1;33(7):1322-1330. doi: 10.1093/humrep/dey118.
6
Use of ICSI in IVF cycles in women with tubal ligation does not improve pregnancy or live birth rates.在输卵管结扎女性的体外受精周期中使用卵胞浆内单精子注射技术并不能提高妊娠率或活产率。
Hum Reprod. 2016 Dec;31(12):2750-2755. doi: 10.1093/humrep/dew247. Epub 2016 Oct 13.
7
Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.1050名女性在一个辅助生殖技术周期(包括所有后续冻融周期)后的累积活产率:一项比较促性腺激素释放激素拮抗剂和促性腺激素释放激素激动剂方案的随机对照试验的次要结果。
Hum Reprod. 2017 Mar 1;32(3):556-567. doi: 10.1093/humrep/dew358.
8
What is the prognosis for a live birth after unexplained recurrent implantation failure following IVF/ICSI?在体外受精/卵胞浆内单精子注射(IVF/ICSI)后不明原因的反复着床失败后,活产的预后如何?
Hum Reprod. 2019 Oct 2;34(10):2044-2052. doi: 10.1093/humrep/dez120.
9
Guidelines for the number of embryos to transfer following in vitro fertilization No. 182, September 2006.体外受精后胚胎移植数量指南,2006年9月,第182号
Int J Gynaecol Obstet. 2008 Aug;102(2):203-16. doi: 10.1016/j.ijgo.2008.01.007.
10
Septate, subseptate and arcuate uterus decrease pregnancy and live birth rates in IVF/ICSI.纵隔、双角及弓形子宫会降低 IVF/ICSI 妊娠率和活产率。
Reprod Biomed Online. 2010 Nov;21(5):700-5. doi: 10.1016/j.rbmo.2010.06.028. Epub 2010 Jun 25.

引用本文的文献

1
Both reduced ovarian reserve and severe semen alterations are overrepresented in couples seeking assisted reproductive technology treatment for the first time: a cross-sectional study.在首次寻求辅助生殖技术治疗的夫妇中,卵巢储备功能降低和严重精液异常的比例都过高:一项横断面研究。
Reprod Health. 2023 Aug 16;20(1):117. doi: 10.1186/s12978-023-01666-0.